Stock listing
1RVMD Stock Price, News, Filings & Events — Revolution Medicines, Inc.
Selected listing: 1RVMD · MIL · EUR · IT
This page tracks Revolution Medicines, Inc.'s 1RVMD:MIL listing on MIL in EUR for IT, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 1RVMD:MIL. 1RVMD:MIL is the stock-level entry point for investors researching Revolution Medicines, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- 1RVMD:MIL
- Asset type
- Stock
- Market cap
- $43.68B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- Exchange
- MIL
- Currency
- EUR
Revolution Medicines, Inc. 1RVMD:MIL stock context
This page tracks Revolution Medicines, Inc.'s 1RVMD:MIL listing on MIL in EUR for IT, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 1RVMD:MIL. 1RVMD:MIL is the stock-level entry point for investors researching Revolution Medicines, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Revolution Medicines, Inc.
Revolution Medicines Announces U.S. FDA Breakthrough Therapy Designation for RASONQUE™ (daraxonrasib) in Combination with Chemotherapy for First Line Metastatic Pancreatic Cancer
September 14, 2026
New England Journal of Medicine Publishes Phase 1/2 Clinical Data on Revolution Medicines’ RASONQUE™ (daraxonrasib) in Metastatic Non-Small Cell Lung Cancer
September 2, 2026
U.S. FDA Approves Revolution Medicines' RASONQUE (daraxonrasib), the First Broad RAS-Targeted Medicine in Metastatic Pancreatic Cancer
August 27, 2026
U.S. FDA Approves Revolution Medicines’ RASONQUE™ (daraxonrasib), the First Broad RAS-Targeted Medicine in Metastatic Pancreatic Cancer
August 26, 2026
Revolution Medicines and BeOne Medicines Announce Clinical Development and Regional Commercialization Collaboration
August 11, 2026
Revolution Medicines, Inc. earnings calls
Revolution Medicines, Inc. (RVMD) Q2 2026 Earnings Call
August 5, 2026 · Replay with transcript and chapters
Revolution Medicines, Inc. (RVMD) Q1 2026 Earnings Call
May 6, 2026 · Replay with transcript and chapters
Revolution Medicines, Inc. (RVMD) Q4 2025 Earnings Call
February 25, 2026 · Replay with transcript and chapters
Revolution Medicines, Inc. (RVMD) Q3 2025 Earnings Call
November 5, 2025 · Replay with transcript and chapters
Revolution Medicines, Inc. (RVMD) Q2 2025 Earnings Call
August 6, 2025 · Replay with transcript and chapters
Revolution Medicines, Inc. (RVMD) Q1 2025 Earnings Call
May 7, 2025 · Replay with transcript and chapters
Research Revolution Medicines, Inc.
Revolution Medicines, Inc. investor report
Review AI stock analysis and investor report context for 1RVMD:MIL.
Revolution Medicines, Inc. company profile
View the public company page for Revolution Medicines, Inc. on 6ix.
Revolution Medicines, Inc. news
Read company news and market updates connected to Revolution Medicines, Inc..
Revolution Medicines, Inc. investor events
Find investor webinars, events, and replay context for Revolution Medicines, Inc..
Alternate listings
RVMD:NASDAQ
US · USD
Alternate listing for Revolution Medicines, Inc.; the primary context on this page is 1RVMD:MIL.
42Z:GETTEX
DE · EUR
Alternate listing for Revolution Medicines, Inc.; the primary context on this page is 1RVMD:MIL.
A2PYWG:LSX
DE · EUR
Alternate listing for Revolution Medicines, Inc.; the primary context on this page is 1RVMD:MIL.
42Z:TRADEGATE
DE · EUR
Alternate listing for Revolution Medicines, Inc.; the primary context on this page is 1RVMD:MIL.
RVMD:BX
CH · CHF
Alternate listing for Revolution Medicines, Inc.; the primary context on this page is 1RVMD:MIL.
RVMD:BOATS
US · USD
Alternate listing for Revolution Medicines, Inc.; the primary context on this page is 1RVMD:MIL.
A2PYWG:LS
DE · EUR
Alternate listing for Revolution Medicines, Inc.; the primary context on this page is 1RVMD:MIL.
RVMD:BMV
MX · MXN
Alternate listing for Revolution Medicines, Inc.; the primary context on this page is 1RVMD:MIL.
42Z:DUS
DE · EUR
Alternate listing for Revolution Medicines, Inc.; the primary context on this page is 1RVMD:MIL.
42Z:FWB
DE · EUR
Alternate listing for Revolution Medicines, Inc.; the primary context on this page is 1RVMD:MIL.
42Z:HAM
DE · EUR
Alternate listing for Revolution Medicines, Inc.; the primary context on this page is 1RVMD:MIL.
42Z:MUN
DE · EUR
Alternate listing for Revolution Medicines, Inc.; the primary context on this page is 1RVMD:MIL.